Key Market Indicators
Polish pharmaceutical production is projected to decline over the next five years, with estimates indicating a drop to approximately €70 million by 2028. This marks a decrease from the current €86 million recorded in 2023, translating to an annual contraction rate of 3%. Despite this forecasted downturn, Poland's pharmaceutical supply has demonstrated a modest growth of 1% annually since 2013. However, in the latest rankings for 2023, Poland secured the 15th position, with the Czech Republic surpassing it at the same €86 million mark. On the broader European stage, Italy, Spain, and Austria have emerged as significant players, occupying the 2nd, 3rd, and 4th positions respectively in the pharmaceutical production rankings.
Latest reports
Poland Pharmaceuticals Market Report- Q1 2025
In Q1 2025, the pharmaceuticals market in Poland is on a trajectory of significant growth, driven by increased consumer spending, strategic international partnerships,...
Poland Pharmaceuticals Market Report- Q4 2024
The Polish pharmaceuticals market in Q4 2024 is experiencing significant growth, driven by demographic shifts, increased healthcare expenditure, and evolving consumer preferences. This...
Poland Pharmaceuticals Market Report - Q4 2024
The Polish pharmaceutical industry remains a key contributor to national economic growth, with significant advancements in biopharmaceuticals and oncology. Despite challenges such as...
